Nutra Pharma Begins Marketing Nyloxin™ Through Direct Distributors
Nutra Pharma announces the direct distribution of their Nyloxin™ line of pain relievers through TCN, a network of distributors in more than 20 countries.September 20, 2012 -- Coral Springs, Florida -- Nutra Pharma Corporation (Pink Sheets: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that they have begun selling Nyloxin through the TCN group of direct distributors. “We are excited to be working with TCN to aggressively market and sell Nyloxin,” explained